采纳股份收盘上涨1.98%，滚动市盈率74.01倍，总市值26.44亿元

Group 1 - The core viewpoint of the news is that Canan Co., Ltd. has experienced a decline in its financial performance, with a significant drop in revenue and net profit in the latest quarterly report [1] - As of July 7, Canan's stock closed at 21.63 yuan, up 1.98%, with a rolling PE ratio of 74.01, marking a new low in 63 days, and a total market capitalization of 2.644 billion yuan [1] - The average PE ratio for the medical device industry is 51.42, with a median of 37.44, placing Canan at the 99th position in the industry ranking [1] Group 2 - Canan Co., Ltd. specializes in the research, production, and sales of injection and puncture instruments and laboratory consumables, and is recognized as a specialized and innovative small and medium-sized enterprise in Jiangsu Province [1] - The latest quarterly report for Q1 2025 shows that Canan achieved an operating income of 72.7093 million yuan, a year-on-year decrease of 34.28%, and a net profit of 7.6802 million yuan, down 69.34%, with a gross profit margin of 31.15% [1] - As of June 30, 2025, Canan had 7,494 shareholders, a decrease of 177 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1]